These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2738887)
21. Antimuscarinic activity of aprophen. Gordon RK; Padilla FN; Moore E; Doctor BP; Chiang PK Biochem Pharmacol; 1983 Oct; 32(19):2979-81. PubMed ID: 6626268 [No Abstract] [Full Text] [Related]
22. Structural comparison of the potent antimuscarinic agent azaprophen hydrochloride with aprophen hydrochloride and structurally related antimuscarinic agents. Karle JM; Karle IL; Chiang PK Acta Crystallogr B; 1990 Apr; 46 ( Pt 2)():215-22. PubMed ID: 2344395 [TBL] [Abstract][Full Text] [Related]
23. Dual mechanism of the antidotal action of atropine-like drugs in poisoning by organophosphorus anticholinesterases. Green DM; Muir AW; Stratton JA; Inch TD J Pharm Pharmacol; 1977 Jan; 29(1):62-4. PubMed ID: 13192 [No Abstract] [Full Text] [Related]
24. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon. Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016 [TBL] [Abstract][Full Text] [Related]
25. Side effects of therapeutic drugs against organophosphate poisoning. Wolthuis OL; Philippens IH; Vanwersch RA Neurotoxicol Teratol; 1989; 11(3):221-5. PubMed ID: 2666846 [TBL] [Abstract][Full Text] [Related]
26. Prophylactic administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfone. Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA J Appl Toxicol; 2014 Oct; 34(10):1096-103. PubMed ID: 24136594 [TBL] [Abstract][Full Text] [Related]
27. The protective actions of some anticholinergic drugs in sarin poisoning. Brimblecombe RW; Green DM; Stratton JA; Thompson PB Br J Pharmacol; 1970 Aug; 39(4):822-30. PubMed ID: 5485153 [TBL] [Abstract][Full Text] [Related]
28. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors. Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864 [TBL] [Abstract][Full Text] [Related]
29. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys. Cho Y; Kim WS; Hur GH; Ha YC Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905 [TBL] [Abstract][Full Text] [Related]
30. A comparison of methods for measuring acetyl cholinesterase activity in blood samples inhibited by carbamates. French MC; Sellers DJ; Wilkinson RG Biochem Pharmacol; 1977 Jul; 26(13):1263-6. PubMed ID: 880272 [No Abstract] [Full Text] [Related]
31. Disposition of aprophen in rats. Aarbakke J; Miura GA; Brown ND; Gray RR; Gordon RK; Doctor BP; Chiang PK J Pharm Pharmacol; 1986 Dec; 38(12):928-30. PubMed ID: 2880971 [TBL] [Abstract][Full Text] [Related]
32. Quaternary and tertiary aldoxime antidotes for organophosphate exposure in a zebrafish model system. Schmidt HR; Radić Z; Taylor P; Fradinger EA Toxicol Appl Pharmacol; 2015 Apr; 284(2):197-203. PubMed ID: 25701203 [TBL] [Abstract][Full Text] [Related]
33. [Protection of mice by carbamates cholinesterase inhibitors against poisoning by armin and its dependence on certain physico-chemical indicators]. Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Kokushkina AV Vopr Med Khim; 1999; 45(6):525-9. PubMed ID: 10761219 [TBL] [Abstract][Full Text] [Related]
34. Substrate and dilution effects on the inhibition of acetylcholinesterase by carbamates. Winteringham FP; Fowler KS Biochem J; 1966 Oct; 101(1):127-34. PubMed ID: 5971773 [TBL] [Abstract][Full Text] [Related]
35. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning. Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of some 3-(1-azabicyclo[2.2.2]octyl) 3-amino-2-hydroxy-2-phenylpropionates: profile of antimuscarinic efficacy and selectivity. Audia VH; McPherson DW; Weitzberg M; Rzeszotarski WJ; Sturm B; Kachur JF; Abreu M; Kaiser C J Med Chem; 1990 Jan; 33(1):307-10. PubMed ID: 2296026 [TBL] [Abstract][Full Text] [Related]
37. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Eckert S; Eyer P; Mückter H; Worek F Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806 [TBL] [Abstract][Full Text] [Related]
38. C. elegans pharyngeal pumping provides a whole organism bio-assay to investigate anti-cholinesterase intoxication and antidotes. Izquierdo PG; O'Connor V; Green AC; Holden-Dye L; Tattersall JEH Neurotoxicology; 2021 Jan; 82():50-62. PubMed ID: 33176172 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning. Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340 [TBL] [Abstract][Full Text] [Related]
40. The use of serial measurement of plasma cholinesterase in the management of acute poisoning with organophosphates and carbamates. Abdullat IM; Battah AH; Hadidi KA Forensic Sci Int; 2006 Oct; 162(1-3):126-30. PubMed ID: 16890390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]